A method to predict radiation-induced mouth sores in cancer patients
Official title: The Prediction of a Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis in Patients With Nasopharyngeal Carcinoma: an Observational Study
Run by Nanfang Hospital, Southern Medical University · NCT06287788 · Data updated 2026-11-12
This study is testing a new way to predict if cancer patients receiving radiation for throat cancer will develop painful mouth sores, to help improve their treatment experience.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Nanfang Hospital, Southern Medical University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | October 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 1, 2024 |
| Trial ID | NCT06287788 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with histologically confirmed nasopharyngeal carcinoma currently receiving radical radiotherapy or chemoradiotherapy.
✕Probably not a fit
Patients with poor oral hygiene, untreated dental diseases, or other significant health issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate a new mucosal contouring method based on swallowing-induced breakthrough pain to predict the occurrence of radiation-induced oropharyngeal mucositis in patients with nasopharyngeal carcinoma. The study will involve multiple centers and focus on patients undergoing radical radiotherapy or chemoradiotherapy. By identifying high-risk patients through this innovative predictive model, the study seeks to improve patient outcomes and quality of life. The researchers will analyze the effectiveness of this method compared to traditional contouring approaches.
Why it matters
Potential benefit: If successful, this study could lead to better prediction and management of severe oropharyngeal mucositis, improving the quality of life for patients undergoing treatment for nasopharyngeal carcinoma.
How similar studies have gone: While traditional methods have shown limited success, this novel approach based on swallowing-induced pain has demonstrated better predictive performance in preliminary results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Provide informed written consent. 2. Age ≥ 18 years. 3. Histologically confirmed as nasopharyngeal carcinoma, and currently undergoing radical radiotherapy or chemoradiotherapy. 4. Complete and continuous records of oral / oropharyngeal mucositis grading, and self-reported swallowing-induced breakthrough pain. Exclusion Criteria: 1. Existence of poor oral hygiene, untreated dental or periodontal diseases, and metal dental restorations. 2. Current untreated or unresolved conditions like unstable heart diseases requiring treatment, and poorly controlled diabetes mellitus. 3. Body mass index (BMI) \<18.5. 4. Unsuitable to participate in current study, according to researchers' assessment.
Where it's running
-
Southern Medical University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Principal investigator: Jian Guan, Ph.D. — Nanfang Hospital, Southern Medical University
- Study coordinator: Jian Guan, Ph.D.
- Email: guanjian5461@163.com
- Phone: +86-13632102247
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observational study on a new method for managing radiation-induced mouth sores in cancer patients
This study is testing a new method to see if it can help predict and manage mouth sores in cancer patients receiving radiation treatment for nasopharyngeal carcinoma.
-
Houyanqing oral liquid to prevent and treat radiation mouth sores in nasopharyngeal cancer
This phase 3 trial will test whether adding Houyanqing oral liquid to standard care can prevent or lessen radiation-caused mouth sores in adults receiving radiotherapy for nasopharyngeal cancer.
-
TCM oral liquid plus herbal mouthwash for radiation‑caused mouth sores in head and neck cancer
This study will test whether taking a Qingying oral liquid and using a modified Da Huang‑Huang Lian Xiexin mouthwash can reduce how often, how long, and how severe radiation‑induced mouth sores are in adults receiving radiotherapy for head and neck cancer.
-
Rice bran for radiation-related mouth sores in head and neck cancer
This trial will try rice bran supplements during radiation to see if adults with head and neck cancer have fewer or less severe mouth sores.
-
Taurine to prevent radiation-induced mouth sores and skin reactions
This trial will test whether taking a daily taurine granule before each radiotherapy session reduces radiation-induced oral mucositis and radiodermatitis in adults receiving postoperative radiotherapy for oral/oropharyngeal cancer.
-
Using hydroxychloroquine to prevent and treat oral mucositis from radiation therapy
This study is testing if hydroxychloroquine can help prevent and treat mouth sores in people getting radiation therapy for head and neck cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.